Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837746 · ClinicalTrials.gov registry record
Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate
A clinical trial, sponsored by Warner Chilcott.
- Completed
- Registry status
- 29
- Enrollment target
NCT00837746: Completed study, sponsored by Warner Chilcott.
NCT00837746 is a clinical trial that has completed, run by Warner Chilcott. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00837746 has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.
Interventions
- DRUG risedronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2003-04 |
| Est. Completion | 2006-10 |
What the finished NCT00837746 record still lists
NCT00837746 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which risedronate is the first listed.
NCT00837746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00837746 about?
NCT00837746 is a clinical study titled "Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate". This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy ...
What is the current status of trial NCT00837746?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2003-04. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00837746?
The interventions under investigation include: risedronate (DRUG).
Who is sponsoring clinical trial NCT00837746?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia